Tag SNPs of the ancestral haplotype 57.1 do not substitute HLA-B*57:01 typing for eligibility to abacavir treatment in the Italian population-Reference-Cited by-同舟云学术

Tag SNPs of the ancestral haplotype 57.1 do not substitute HLA-B*57:01 typing for eligibility to abacavir treatment in the Italian population

Published:2012-02 Issue:3 Volume:13 Page:247-249
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Badulli Carla¹,Sestini Roberta²,Sbarsi Ilaria¹,Baroncelli Marta²,Pizzochero Cinzia¹,Martinetti Miryam¹,Porfirio Berardino³

Affiliation:

1. Laboratorio di Immunogenetica, Servizio di Immunoematologia e Medicina Trasfusionale, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

2. Unità di Genetica Medica, Dipartimento di Fisiopatologia Clinica, Università degli Studi di Firenze, Firenze, Italy

3. Unità di Genetica Medica, Dipartimento di Fisiopatologia Clinica, Università degli Studi di Firenze, Firenze, Italy.

Abstract

A letter in response to: Sanchez-Giron F, Villegas-Torres B, Jaramillo-Villafuerte K et al. Association of the genetic marker for abacavir hypersensitivity HLA-B*5701 with HCP5 rs2395029 in Mexican Mestizos. Pharmacogenomics 12(6), 809–814 (2011).

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs.11.168

Reference10 articles.

1. Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

2. HLA-B*5701 Screening for Hypersensitivity to Abacavir

3. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant

4. TheHCP5Single‐Nucleotide Polymorphism: A Simple Screening Tool for Prediction of Hypersensitivity Reaction to Abacavir

5. Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of the PG x‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing;Clinical Pharmacology & Therapeutics;2019-06-12

2. Cross-ethnicity tagging SNPs for HLA alleles associated with adverse drug reaction;The Pharmacogenomics Journal;2018-08-10

3. Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe;BMC Medical Genomics;2017-06-19

4. Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe;2017-01-05

5. Validation of two commercial real-time PCR assays for rapid screening of the HLA-B*57:01 allele in the HIV clinical laboratory;Journal of Virological Methods;2016-11